| 2017-2018 |
Comparing vaginal microflora diversity between healthy and cervical cancer women for identifying isolates having probiotic and anticancer potential |
Bharati Hospital, Pune |
DST-SERB-WOS-A |
Three years |
| 2017-2018 |
Early Interventions to Support Trajectories for Healthy Life in India (EINSTEIN). Healthy Life Trajectories Initiative (HeLTI) |
CSI Holdsworth Memorial Hospital, VMH Saragur, CCMB Hyderabad, IRSHA Pune, KEM Pune, Suryanarayana KG |
DBT |
Five years |
| 2017-2018 |
Investigating Mechanisms Leading to Preeclampsia |
Bharati Hospital, Gupte Hospital, CCMB |
ICMR |
Five years Six months |
| 2017-2018 |
Establishment of Indian norovirus surveillance network |
(1) Centers for Disease Control and Prevention, USA
(2) Christian Medical College, Vellore
(3) National Institute of Epidemiology, Chennai
(4) Sri Ramchandra Medical College, Chennai |
CDC, USA |
Three years |
| 2018-2019 |
Evaluating anticancer activity of Homeopathic preparation of Linum Usitatissimum in Breast cancer cell lines |
Homeopathy college, Bharati Vidyapeeth (Deemed to be) University, Pune |
CCRH-AYUSH |
Two years |
| 2018-2019 |
Influence of Maternal One-carbon (1C) Metabolism in Placental Function, Fetal Growth and Programming |
King Edward Vii Memorial Hospital, Pune |
DBT |
Three years |
| 2019-2020 |
Comparing vaginal microflora diversity between healthy and cervical cancer women for identifying isolates having probiotic and anticancer potential |
Bharati Hospital , Pune |
DST-SERB-WOS-A |
Two years |
| 2019-2020 |
Epigenetic regulation of angiogenic factors in assisted reproductive technology (ART) and non-ART derived placentae |
Gupte hospital and research centre |
DBT |
Three years |
| 2019-2020 |
Extraction of bioactive lignan and development of value added products from flaxseed
|
Real World Nutrition Laboratory Foundation, Pune
|
Funded project |
Three years |
| 2020-2021 |
Phytochemical standardization and evaluation of anti-cancer and immunomodulatory activity of Unani formulation, Itrifal Gudadi.
|
Poona college of Pharmacy
|
|
Three years |
| 2020-2021 |
In vitro assessment of Naga parpam (traditionally formulated Siddha drug) against SARS-CoV-2 virus
|
Siddha Clinical Research Unit (SCRU), Bengaluru
|
IRSHA |
Six months |
| 2020-2021 |
Research collaboration between IRSHA and D.Y. Patil Medical College, Pune
|
Dr. D.Y. Patil Medical College, Pune
|
IRSHA funds |
Three years |
| 2022-2023 |
OPTIMISE: Optimal preconception nutrition to offset inflammation and non-communicable disease risk in pregnant women and their children
|
CSI Holdsworth Memorial Hospital
|
University of Southampton |
Two years |
| 2022-2023 |
Exploring the role of maternal fatty acids, placental fatty acid metabolism, and inflammation in determining infant health in gestational diabetes mellitus
|
Bharati Hospital, Gupte hospital and research centre
|
DBT |
Three years |
| 2022-2023 |
Assessment of antiviral activity of Microbial compounds against SARS-CoV-2
|
BVDU-RGITBT
|
IRSHA |
One year |